Evidence map›Paper›PMID 29569002›Full record

ArticleDigestive diseases and sciences2018

Mast Cells and Serotonin Synthesis Modulate Chagas Disease in the Colon: Clinical and Experimental Evidence.

Vinicius Kannen, Juliana Y Sakita, Zumira A Carneiro, Michael Bader, Natalia Alenina, Regina R Teixeira, Enio C de Oliveira, Mariângela O Brunaldi, Bianca Gasparotto, Daniela C Sartori and 6 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Vinicius KannenDepartment of Toxicology, Bromatology, and Clinical Analysis, University of Sao Paulo, Ribeirão Preto, 14040-903, Brazil. vinicius.kannen@fcfrp.usp.br.
Juliana Y SakitaDepartment of Toxicology, Bromatology, and Clinical Analysis, University of Sao Paulo, Ribeirão Preto, 14040-903, Brazil.
Zumira A CarneiroDepartment of Toxicology, Bromatology, and Clinical Analysis, University of Sao Paulo, Ribeirão Preto, 14040-903, Brazil.
Michael BaderMax Delbrück Center for Molecular Medicine, Berlin, Germany.
Natalia AleninaMax Delbrück Center for Molecular Medicine, Berlin, Germany.
Regina R TeixeiraDepartment of Toxicology, Bromatology, and Clinical Analysis, University of Sao Paulo, Ribeirão Preto, 14040-903, Brazil.
Enio C de OliveiraDepartment of Surgery, Federal University of Goias, Goiânia, Brazil.
Mariângela O BrunaldiDepartment of Pathology, University of Sao Paulo, Ribeirão Preto, Brazil.
Bianca GasparottoDepartment of Toxicology, Bromatology, and Clinical Analysis, University of Sao Paulo, Ribeirão Preto, 14040-903, Brazil.
Daniela C SartoriDepartment of Biochemistry and Immunology, University of São Paulo, Ribeirão Preto, Brazil.
Cleverson R FernandesDepartment of Pathology, University of Sao Paulo, Ribeirão Preto, Brazil.
João S SilvaDepartment of Biochemistry and Immunology, University of São Paulo, Ribeirão Preto, Brazil.
Marcus V AndradeDepartment of Clinical Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Wilson A SilvaDepartment of Genetics, University of Sao Paulo, Ribeirão Preto, Brazil.
Sergio A UyemuraDepartment of Toxicology, Bromatology, and Clinical Analysis, University of Sao Paulo, Ribeirão Preto, 14040-903, Brazil.
Sérgio B GarciaDepartment of Pathology, University of Sao Paulo, Ribeirão Preto, Brazil.
Universidade de São Paulo · BRMax Delbrück Center · DEUniversidade Federal de Goiás · BRUniversidade Federal de Minas Gerais · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 443376/2014-0Fundação de Amparo à Pesquisa do Estado de São Paulo 2014/06428-5Russian Science Foundation 14-50-00069
6 · The paper itself

Abstract

backgroundTrypanosoma cruzi (T. cruzi) infects millions of Latin Americans each year and can induce chagasic megacolon. Little is known about how serotonin (5-HT) modulates this condition. Aim We investigated whether 5-HT synthesis alters T. cruzi infection in the colon. MATERIALS AND

methodsForty-eight paraffin-embedded samples from normal colon and chagasic megacolon were histopathologically analyzed (173/2009). Tryptophan hydroxylase 1 (Tph1) knockout (KO) mice and c-Kit

resultsIn both humans and experimental mouse models, the serotonergic system was activated by T. cruzi infection (p < 0.05). While treating Tph1KO mice with 5-HT did not significantly increase parasitemia in the colon (p > 0.05), rescuing its synthesis promoted trypanosomiasis (p < 0.01). T. cruzi-related 5-HT release (p < 0.05) seemed not only to increase inflammatory signaling, but also to enlarge the pericryptal macrophage and mast cell populations (p < 0.01). Knocking out mast cells reduced trypanosomiasis (p < 0.01), although it did not further alter the neuroendocrine cell number and Tph1 expression (p > 0.05). Further experimentation revealed that pharmacologically inhibiting mast cell activity reduced colonic infection (p < 0.01). A similar finding was achieved when 5-HT synthesis was blocked in c-Kit

conclusionWe show that mast cells may modulate the T. cruzi-related increase of 5-HT synthesis in the intestinal colon.

Indexed as

AdultAgedAnimalsCase-Control StudiesChagas DiseaseColonHost-Pathogen InteractionsHumansIntestinal Diseases, ParasiticMaleMast CellsMegacolonMice, Inbred C57BLMice, KnockoutMiddle AgedProto-Oncogene Proteins c-kitProto-Oncogene Proteins c-kitSerotoninTph1 protein, mouseTryptophan HydroxylaseEnteric neuronsIntestinesNeuroendocrine systemParasites

Identifiers

PMID29569002
OpenAlexW2794242475

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.